⌕
Labcorp Holdings · LH · NYSE
Tenet 43 · Weak
Compare
$372.46+0.53%At closeTenet 43 · Weak
$372.46+1.98 (+0.53%)
At close: Nov 16, 2026, 4:00 PM ET· NYSE · USD

Labcorp Holdings (LH) News

What's actually happening: chronological and provenance-stamped. News is context, not a signal.

Sources News publishers NewsHow we compute thisNot investment advice

● Defense WorldNov 15, 2026 · 13:01 ET
Labcorp (NYSE:LH) EVP Sells $744,080.00 in Stock

Labcorp Holdings Inc. (NYSE: LH - Get Free Report) EVP Brian Caveney sold 2,000 shares of the stock in a transaction on Tuesday, November 10th. The shares were sold at an average price of $372.04, for a total value of $7…

● Defense WorldNov 15, 2026 · 12:15 ETEARNINGS EXPECTED BY FEB 12
Fifth Third Bancorp Sells 6,956 Shares of Labcorp Holdings Inc. $LH

Fifth Third Bancorp lessened its position in Labcorp Holdings Inc. (NYSE: LH) by 12.4% during a recent quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 4…

● Defense WorldNov 15, 2026 · 12:15 ETEARNINGS EXPECTED BY FEB 12
Labcorp Holdings Inc. $LH Stock Sold by Eurizon Capital SGR S.p.A.

Eurizon Capital SGR S.p.A. lowered its position in Labcorp Holdings Inc. (NYSE: LH) by 16.3% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. …

● MarketBeatNov 13, 2026 · 11:15 ETEARNINGS EXPECTED BY FEB 12
Labcorp's Lab Growth Surges as $125 Million Reimbursement Risk Looms

Labcorp NYSE: LH Chief Financial Officer Julia Wang said strength in the company's central laboratory business and diagnostic testing helped drive third-quarter growth, while management prepares for a potential reduction…

● The Motley FoolNov 12, 2026 · 19:21 ETEARNINGS EXPECTED BY FEB 12
Labcorp: 3 Key Takeaways for Long-Term Investors

Revenue grew 7% to $3.8 billion in the third quarter. Proposed Medicare fee schedule changes present a $125 million potential impact.…

● Seeking AlphaNov 11, 2026 · 01:30 ET
Labcorp Holdings Inc. (LH) Presents at 2026 UBS Global Healthcare Conference Transcript

Labcorp Holdings Inc. (LH) Presents at 2026 UBS Global Healthcare Conference Transcript…

● Zacks Investment ResearchNov 10, 2026 · 15:01 ET
Is Now the Right Time to Hold Labcorp Stock in Your Portfolio?

LH's specialty testing growth, AI-driven efficiencies and expanding margins support its outlook, though currency pressures and competition pose risks.…

● Defense WorldNov 6, 2026 · 02:41 ET
Labcorp (NYSE:LH) Hits New 52-Week High on Analyst Upgrade

Labcorp Holdings Inc. (NYSE: LH - Get Free Report)'s stock price reached a new 52-week high on Thursday after HSBC upgraded the stock from a hold rating to a buy rating. HSBC now has a $410.00 price target on the stock. …

● Zacks Investment ResearchNov 5, 2026 · 10:51 ET
Labcorp Holdings (LH) is a Top-Ranked Momentum Stock: Should You Buy?

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.…

● PRNewsWireNov 4, 2026 · 08:00 ETCOMPANY'S OWN WORDS
Labcorp to Speak at the UBS Global Healthcare Conference

BURLINGTON, N.C., Nov. 4, 2026 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today that Chief Financial Officer Julia Wang will speak at the UBS Global…

● Zacks Investment ResearchOct 30, 2026 · 10:40 ET
Labcorp Holdings (LH) is a Top-Ranked Value Stock: Should You Buy?

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.…

● Defense WorldOct 30, 2026 · 03:48 ETEARNINGS EXPECTED BY FEB 12
Labcorp Q3 Earnings Call Highlights

Labcorp (NYSE: LH) reported third-quarter 2026 revenue growth, margin expansion and double-digit adjusted earnings-per-share growth, prompting the laboratory services company to raise the midpoint of its full-year revenu…

● Seeking AlphaOct 29, 2026 · 08:15 ETEARNINGS EXPECTED BY FEB 12
Labcorp Holdings: The Optimism May Be Going Overboard (Rating Downgrade)

Labcorp Holdings raised guidance, triggering a sharp stock price rally. I view LH as a compelling long-term growth story, but current valuation is stretched. The price-earnings ratio approaching 20 exceeds my preferred r…

● Seeking AlphaOct 28, 2026 · 14:50 ETEARNINGS EXPECTED BY FEB 12
Labcorp Holdings Inc. (LH) Q3 2026 Earnings Call Transcript

Labcorp Holdings Inc. (LH) Q3 2026 Earnings Call Transcript…

● BenzingaOct 28, 2026 · 13:54 ETEARNINGS EXPECTED BY FEB 12
Labcorp Targets Margin Growth, Absorbs Policy Headwinds

Labcorp Holdings (NYSE:LH) stock is trading at a 52-week high after the company reported upbeat third-quarter earnings and raised its fiscal outlook.…

● Zacks Investment ResearchOct 28, 2026 · 11:26 ETEARNINGS EXPECTED BY FEB 12
LH Stock Rises on Q3 Earnings and Revenue Beat, '26 View Up

Labcorp shares rise as Q3 earnings and revenues beat estimates, both segments deliver growth, margins expand and the company raises its 2026 financial outlook.…

● Zacks Investment ResearchOct 28, 2026 · 10:31 ETEARNINGS EXPECTED BY FEB 12
Compared to Estimates, Labcorp (LH) Q3 Earnings: A Look at Key Metrics

Although the revenue and EPS for Labcorp (LH) give a sense of how its business performed in the quarter ended September 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the …

● Zacks Investment ResearchOct 28, 2026 · 09:36 ETEARNINGS EXPECTED BY FEB 12
Labcorp Holdings (LH) Q3 Earnings and Revenues Surpass Estimates

Labcorp Holdings (LH) came out with quarterly earnings of $4.78 per share, beating the Zacks Consensus Estimate of $4.65 per share. This compares to earnings of $4.18 per share a year ago.…

● PRNewsWireOct 28, 2026 · 06:50 ETCOMPANY'S OWN WORDSEARNINGS EXPECTED BY FEB 12
Labcorp Reports Strong 2026 Third Quarter Results; Raises Full Year 2026 Guidance

Results from operations for third quarter 2026 versus third quarter 2025: Revenue: $3.81 billion vs. $3.56 billion, up 6.9% Diluted EPS: $3.22 vs.…

● Zacks Investment ResearchOct 27, 2026 · 13:36 ET
Waters & Labcorp Expand Access to FDA-Approved HPV Screening Tests

WAT partners with Labcorp to expand access to FDA-approved HPV testing by late 2026, potentially boosting diagnostics adoption and cervical cancer screening.…

● PRNewsWireOct 23, 2026 · 08:00 ET
Waters and Labcorp to Expand Access to Cervical Cancer Screening with the Most Comprehensive FDA-Approved HPV Testing Option Beginning in Late 2026

Labcorp intends to be the first commercial laboratory to offer FDA-approved HPV testing with the BD Onclarity™ HPV Assay across clinician-collected and self-collected screening options in clinic, patient service center, …

● PRNewsWireOct 22, 2026 · 16:30 ETCOMPANY'S OWN WORDS
Labcorp, Charles River and FDA Announce Research Collaboration to Advance Preclinical Methods for Evaluating Drug Abuse Potential

Research collaboration aims to strengthen the science used to assess whether new medicines could be abused, supporting safer drug development and more informed regulatory decisions BURLINGTON, N.C., Oct. 22, 2026 /PRNews…

● Zacks Investment ResearchOct 22, 2026 · 12:41 ET
LH vs. DHR: Which Stock Is the Better Value Option?

Investors interested in Medical Services stocks are likely familiar with Labcorp Holdings (LH) and Danaher (DHR). But which of these two stocks is more attractive to value investors?…

● PRNewsWireOct 21, 2026 · 06:50 ETCOMPANY'S OWN WORDSEARNINGS EXPECTED BY FEB 12
Labcorp Declares Quarterly Dividend

BURLINGTON, N.C., Oct. 21, 2026 /PRNewswire/ -- Labcorp Holdings Inc. (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today that its Board of Directors has declared a cash divid…

● GlobeNewsWireOct 20, 2026 · 08:30 ET
Myriad Genetics and Labcorp Announce Definitive Agreement for Myriad to Sell Prenatal Health Testing Business to Labcorp

SALT LAKE CITY and BURLINGTON, N.C., Oct. 20, 2026 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, and Labcorp (NYSE: LH), a global leader in inn…

● PRNewsWireOct 15, 2026 · 07:30 ETCOMPANY'S OWN WORDS
Labcorp Enters into Agreement with OPKO Health to Acquire Select Assets of BioReference Health

Acquisition will expand access to clinical laboratory services, including a broad specialty testing menu for patients and providers nationwide BURLINGTON, N.C. and MIAMI, Fla.…

● PRNewsWireOct 13, 2026 · 08:00 ETCOMPANY'S OWN WORDS
Labcorp and Arianna Huffington's Thrive Global Collaborate to Launch Thrive 5 Health Test

First lab test offered in collaboration with Thrive Global Combines Labcorp's scientific expertise with Thrive Global's behavior change approach to help consumers turn health insights into healthier daily habits Delivers…

● PRNewsWireSep 30, 2026 · 08:30 ETCOMPANY'S OWN WORDSEARNINGS EXPECTED BY FEB 12
Labcorp to Announce Third Quarter 2026 Financial Results on October 28, 2026

BURLINGTON, N.C., Sept. 30, 2026 /PRNewswire/ -- Labcorp Holdings Inc.…

● PRNewsWireSep 10, 2026 · 07:00 ETCOMPANY'S OWN WORDSEARNINGS EXPECTED BY FEB 12
Labcorp Highlights Strategic Priorities Driving Durable Growth and Shareholder Value at 2026 Investor Day

Reaffirms full-year 2026 guidance Provides long-term outlook through 2029, with compound annual revenue growth of 5% to 8% and compound annual adjusted earnings per share (EPS) growth of 8.5% to 11.5% Outlines strategic …

Kept in their own lane. A press release is the company talking, not reporting.

Expected by Feb 12. Report dates come from the data provider's upcoming-earnings feed and are its estimate, not a date the company has set.

Article counts from the last market-wide feed page, across every symbol we track and not just LH · day move from the quote feed. Equal counts are listed alphabetically, not ranked. Coverage ≠ importance.

The feed is purely chronological. No materiality ranking, no hidden sentiment score. Timestamps are publisher-reported and arrive with no timezone, so they are read and shown on the US market clock (ET); thumbnails come from each article's image field; day moves from the quote feed. Copies of the same story are collapsed on link or normalized headline, and a company's press release is kept over any syndicated copy of it; "company's own words" means the release title leads with the company's name and the wire names no other organisation first as its issuer; "earnings-tied" is a keyword match while a report date is upcoming. Not investment advice.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.